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Abstract 
Due  to  an  increasing  life  expectance,
osteoarthritis (OA) is one of the most common
chronic diseases. Although strong efforts have
been  made  to  regenerate  degenerated  joint
cartilage, OA is a progressive and irreversible
disease up to date. Among other factors the
dysbalance  between  free  radical  burden  and
cellular  scavenging  mechanisms  defined  as
oxidative stress is a relevant part of OA patho-
genesis.  Here,  only  little  data  are  available
about the mediation and interaction between
different joint compartments. The article pro-
vides a review of the current literature regard-
ing the influence of oxidative stress on cellular
aging, senescence and apoptosis in different
joint compartments (cartilage, synovial tissue
and subchondral bone). Free radical exposure
is known to promote cellular senescence and
apoptosis.  Radical  oxygen  species  (ROS)
involvement in inflammation, fibrosis control
and  pain  nociception  has  been  proven.  The
data from literature indicates a link between
free radical burden and OA pathogenesis medi-
ating local tissue reactions between the joint
compartments. Hence, oxidative stress is like-
ly not only to promote cartilage destruction but
also to be involved in inflammative transfor-
mation, promoting the transition from clinical-
ly silent cartilage destruction to apparent OA.
ROS  induced  by  exogenous  factors  such  as
overload,  trauma,  local  intraarticular  lesion
and consecutive synovial inflammation cause
cartilage  degradation.  In  the  affected  joint,
free radicals mediate disease progression. The
interrelationship between oxidative stress and
OA etiology might provide a novel approach to
the comprehension and therefore modification
of disease progression and symptom control.
Introduction
Osteoarthritis (OA) is a common and pro-
gressive chronic disease leading to impaired
joint  function  and  can  result  in  immobility
mostly in elderly people.
1 The prevalence of OA
increases  significantly  in  advanced  age.
Radiographic evaluation of knee x-ray images
taken  from  the  Framingham  osteoarthritis
study  showed  alterations  in  K/L  (Kellgren/
Lawrence  Grade)>  or  =2  in  44%  of  parents
(mean  age  72  years)  and  22%  of  offspring
(mean age 54 years).
2 Although several risk
factors like overweight or the family history of
OA are well known, the mechanisms on the
cellular level leading from the presence of risk
factors to cartilage degeneration are not com-
pletely  understood  in  detail.  Besides  other
agents,  recent  data  focus  on  oxidative  and
nitrosative stress as one aspect involved in the
pathogenesis of OA.
3 In the course of the grow-
ing knowledge about the relevance of free rad-
icals for cellular ageing, their involvement in
degenerative diseases of the joint came into
focus of more detailed investigations.
4
Method of data selection
We present a review of the current literature
over the relevance of free radicals in OA patho-
genesis.  Here,  all  relevant  original  publica-
tions  in  this  topic  documented  in  the  USA
National Library of Medicine and the library of
the  National  Institutes  of  Health,  USA  were
considered. Reviews and single case reports
were excluded. The online search was conduct-
ed by use of the terms oxidative stress, oxida-
tive damage and radical oxygen species, each of
them  combined  with  the  search  term
osteoarthritis. This yielded a cumulative num-
ber of 203 studies. Of these results, 33 were
identified as review or case report, leaving 170
relevant studies for this review. The relevance
of the studies cited herein was considered by
actuality, included sample size and methods as
well as by the number of being cited evaluated
by  use  of  ISI  Web  of  Science®.  Finally,  the
selected  studies  are  discussed  critically  and
new  insights  were  given  to  this  innovative
research field.
Lessons from actual studies
The silent way of osteoarthritis
OA is not limited to articular cartilage only,
but also affects the subchondral bone, as well
as the adjacent connective tissue and the syn-
ovial  membrane  resulting  in  pain,  swelling,
progressive deformity and instability. Although
OA occurs in many joints, the knee, hip, hand
and facet joints are mostly affected.
5
Yet, patients suffering from OA often show a
discrepancy between objective findings gath-
ered in x-ray or magnetic resonance imaging
(MRI) examinations and patient-reported pain
and functional restrictions.
6 The sudden onset
of disabling joint pain and articular effusion is
one typical clinical feature of decompensation
indicating the term activated OA. On a cellular
and subcellular level, proinflammatory agents
such as nitric oxide, interleukin 1 (IL-1), and
tumor  necrosis  factor  (TNF)  α are  overex-
pressed in chondrocytes and joint stromal cells
in OA.
7,8
The influence of free radicals on
osteoarthritis development
Many studies focused on damaging effects
of oxidative and nitrosative agents,
9-11 whereas
in the following the differential role of Radical
oxygen  species  (ROS)  and  radical  nitric
species  (RNS)  in  osteoarthritis  came  into
focus. A study comparing the effects of nitric
oxide  and  oxidative  dysbalance  in  OA  and
rheumatoid arthritis postulated a major role of
nitric  oxide  (NO)  to  modulate  chondrocyte
function in OA.
12 In contrast to the uncoupling
effect  of  ROS  on  synovium  inflammation,
13
ROS  have  been  shown  to  downregulate  the
expression  of  pro-  inflammatory  genes  in
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chondrocytes.
14 The involvement of free radi-
cals  in  signal  transduction  highlighted  that
within evolution higher life forms took advan-
tage of the ability of ROS to mediate signals
over cell margins in a system consisting of dis-
crete compartments like joint.
15,16
Regarding radical nitrosative species nitric
oxide is subject to extensive research. It is pro-
duced by the closely regulated nitric oxide syn-
thase (NOS) using the substrate L-arginine.
Several isoforms of NOS have been identified
in OA joint tissue. Functional relevance of con-
stitutional  neuronal  NOS  (nNOS)
17 and
inducible  NOS  (iNOS)
18 in  OA  pathogenesis
has been shown. Furthermore, osteoarthritis-
affected NOS (OA-NOS) only detectable in OA
cartilage was described,
19 showing properties
similar to nNOS and iNOS. Evidence for NOS
mediated signaling in OA was found in carti-
lage
20and synovium.
21Here, a relative deficit in
the production of natural antagonists of the IL-
1 receptor has been demonstrated, and could
possibly be related to an excess production of
nitric oxide in OA tissues.
22 In cartilage tissue,
chondrocyte  interleukin-1-converting  enzyme
and  interleukin-18  levels  are  shown  to  be
mediated  by  nitric  oxide.
23,24 Another  study
demonstrated that proinflammatory mediators
such as IL-1 give in turn rise to NO formation
in inflammative joints.
25 The upregulation of
iNOS related NO production is a well known
feature of IL-1.
26 Nitric oxide was suspected to
play a major role in the influence of mitochon-
drial function in OA (Figure 1). Furthermore,
NO  dependent  intracellular  signaling  in  OA
nociception is subject of recent investigation.
27
The role of nitrosative and oxidative
stress in the three compartments 
of joint
There is evidence that alterations of sub-
chondral  bone
28 and  synovial  cells/fluid    are
crucial for OA pathogenesis, which stands in
contrast to the classic focus on cartilage degra-
dation in OA development. The joint is hence
to be considered as a dynamic system consist-
ing of three discrete but permanently interact-
ing compartments.
29
Cartilage tissue is classified with conjunc-
tive tissue, deriving from mesenchymal stem
cells during embryonic development. Oxidative
dysbalance  in  cartilage  is  an  effect  of  two
major  mechanisms.  First, it  occurs  when
antioxidative  capacity  is  depleted.  A  more
oxidative  intracellular  state  is  a  cause  for
pathologic  alterations  in  osteoarthritic  carti-
lage.
13
Second,  nutrition  of  articular  cartilage  as
avascular  tissue  containing  chondrocytes
embedded into a large amount of extracellular
matrix is dependent on diffusion from synovial
-  and  subchondral  bone  compartment.
30
Oxygen  and  metabolic  end  products  have  to
diffuse over relative long distances, resulting
in low O2 tension in cartilage tissue.
31 A rise of
O2 tension in cartilage tissue as is typical for
inflammation  in  turn  enhances  free  radical
formation, an interesting finding in the con-
text  of  cartilage  degeneration  in  chronically
irritated joints. 
Furthermore,  radical  oxygen  species  pro-
duced by the oxidative metabolic turnover of
cartilage tissue are a substantial factor for the
maintenance of intracellular signaling.
16,32
The hyaline cartilage of the joint provides
profoundly  elastic  properties  under  pressure
and shear stress. These biomechanical charac-
teristics are based on the cartilage matrix com-
position which consists mostly of collagen type
II and a large aggregating proteoglycan, aggre-
can.33,34 Articular  cartilage  is  not  only  firm
under permanent movement and shear stress,
a condition that would be hostile for nearly all
other tissues.35 Evidence was found, that nor-
mal cartilage function is maintained only in
tissue being exposed to moderate movement
and pressure.36-39 A very recent study is one of
the first to demonstrate that physical exercise
can  reduce  oxidative  stress  in  joints  with
experimental OA on an animal model.40
In  contrast,  excessive  repetitive  load  was
proven to induce chondrocyte apoptosis, a fact
which  points  out  the  relevance  of  injurious
cartilage compression for OA pathogenesis.41,42
Mechanical loading that exceeds the tolerance
of the articular surface was indirectly identi-
fied to cause oxidative stress by the decrease
of  cell  death  after  submission  of  antioxi-
dants.43,44 A study on cartilage explants showed
an increase of ROS synthesis after admission
of mechanical load.
45 Furthermore, some data
indicate that radical nitrogen species act as
mediators of cell death after mechanical over-
use and injury to cartilage.
46These findings are
in accordance to the fact that also excessive
shear  stress  is  able  to  induce  chondrocyte
death mediated by ROS.
47
Once produced as a response to mechanical
overload,  free  radical  diffusion  into  all  joint
compartments is promoted by cyclic compres-
sion during gait. Fluctuation of synovial fluid
and squeezing of fluid from cartilage tissue in
static pressure phases causes a constant inter-
change of fluid between cartilage tissue and
synovial compartment.
48 It is very likely that in
joint inflammation this mechanism increases
the exposure of cartilage against radical oxy-
gen species. 
Review
Figure 1. A major source structure of reactive oxidative molecules is the mitochondrion.
The energy metabolism produces in oxidative phosphorylation ROS as side product of
normal  cellular  metabolism.  Disruption  of  chondrocyte  respiration  by  nitric  oxide
induced inhibition of electron transport has been discussed to be centrally involved in
chondrocyte functional compromise.
99 In contrast a very recent study showed that the
mitochondrion is a target of oxidative damage, mainly by NO related TNF-α and IL-1
induction damage of mitochondrial DNA.
100 Mitochondrial damage by ROS/RNS has
been addressed to be an important factor for chondrocyte functional compromise and
apoptosis induction. Nitric oxide is released with several proinflammative factors by syn-
ovial cells as a result of inflammative transition.
101 Nuclear transcription factor kB (NF- k
B), which is involved in the upregulation of several inflammatory genes,
58 is an important
factor for ROS/RNS induced inflammatory transition of synovial membrane. The figure
shows in addition to mitochondrial damage by nitric oxide the directly damaging effects
of ROS on nuclear DNA, intracellular structures and extracellular matrix.[Orthopedic Reviews 2010; 2:e23] [page 97]
The synovial compartment consists of the
synovial membrane and the synovial fluid. The
implications of this joint compartment for OA
development,  also  in  relationship  with  ROS,
were extensively investigated during the last
decade. The synovial cells are involved in the
synthesis of the synovial fluid, an ultrafiltrate
of  the  serum  enriched  with  products  of  the
cells.
49 It forms a capillary layer in the healthy
joint  and  provides  the  minimization  of  fric-
tion.
50 Here,  a  large  amount  of  cross  linked
hyaluronan,  an  anionic  non-sulfated  gly-
cosaminoglycan,  contributes  substantially  to
the  rheologic  properties  of  joint  fluid.
51
Oxidative  stress,  namely  peroxynitrit,  has
been  shown  in  vitro to  depolymerise  gly-
cosaminoglycans,
52,53 whereas  hyaluronan
degradation can be prevented by antioxidative
agents.
54 In conclusion, hyaluronan acts as a
ROS scavenger in the joint by a competition
with other substrates suitable for the reaction
with radical oxygen molecules.
A reduced antioxidative capacity in synovial
fluid of osteoarthritic joints has been found,
55
investigating mainly extracellular superoxide
dismutase (EC-SOD or SOD3) in irritated ver-
sus  late  stage  OA  joints.  Here,  the  reduced
antioxidative capacity was described as a dis-
ability of the joint to adapt to increased oxida-
tive stress in late stage OA. Finally, the ques-
tion if oxidative stress is an initial cause or
secondary consequence of OA remains unan-
swered.
The  inflammatory  transformation  of  syn-
ovial membrane in OA is observed frequently
in arthroscopic examination. Distinct synovitis
involving infiltration of activated B cells and T
lymphocytes and overexpression of proinflam-
matory mediators is a common finding in his-
tological  and  arthroscopic  examination  of
patients suffering from OA.
56 Increased levels
of IL-1α, IL-1β, and TNF-α could be found in
synovial membranes from patients with OA.
57
Radical oxygen species play a major role in
inflammatory  intracellular  signaling  mecha-
nisms of synovia.
13 The activation of nuclear
transcription factor (NF)-k B that is implicat-
ed in the inflammatory response in vascular
endothelium and type A synovial lining cells is
a feature of synovial tissue from both RA and
OA  patients.
58 Furthermore,  synovitis  is  sec-
ondary to a local increase of the pro-inflamma-
tory enzymes cyclooxygenase-2 and iNOS.
56 NO
mediates the effects of a number of proinflam-
matory cytokines, including interleukin-1 (IL-
1)  and  tumor  necrosis  factor  (TNF)-α.
22 A
canine  in  vivo model  demonstrated  a  NO
dependent  up-regulation  of  IL-1-converting
enzyme  in  chondrocytes,  providing  another
interrelationship between synovial inflamma-
tion  and  cartilage  degradation  by  paracrine
free radical signaling.
23
One  possible  mechanism  leading  from
inflammatory transition of the synovial mem-
brane to joint degeneration is ROS/RNS pro-
duction by synovial cells
59 (Figure 2). Synovial
inflammation was discussed to impair the abil-
ity  of  chondrocytes  to  balance  anabolic  and
catabolic activities in extracellular matrix for-
mation.
60 A  transgenic  mouse  model  yielded
evidence that increased ROS production is a
relevant cause for chondrocytic death and acti-
vation  of  matrix  metalloproteinases  in  an
inflammatory joint disease.
61
At third the subchondral bone is involved in
ROS mediated OA pathogenesis. In advanced
stages of OA, first hypertrophic alterations of
the bone presented by subchondral sclerosis
and osteophytes occur; later on osteoclast acti-
vation  leads  to  local  bone  resorption  (bone
cysts) affecting the peri-articular bone.
62 The
subchondral bone together with articular carti-
lage is considered as a unit, playing an impor-
tant role in OA disease development
63 particu-
larly on the bounding surface between bone
and cartilage. Only few studies have focused
on the action of radical oxygen species in the
context of subchondral bone remodeling.
31 One
study demonstrates the effect of total fraction
of  avocado/soybean  unsaponifiables  on  bone
remodeling  in  experimental  canine
osteoarthritis.
64 Here, after drug admission a
significantly reduced expression of inducible
nitric oxide synthase in cartilage together with
decreased  bone  remodeling  is  reported.  Yet,
the exact mechanisms of bone remodeling in
relationship with ROS action are only partially
understood.
The implication of cellular 
senescence, apoptosis and ageing
in osteoarthritis  
The  heterogeneity  of  OA  leads  to  a  huge
variety of known etiopathogenic factors. Yet, in
literature  review  there  is  a  common  thread
regarding  the  uniform  presentation  of  end
stage OA.
65,66 There are mainly three pathologic
alterations in joint that represent OA disease
development  on  the  cellular  level.  Cellular
senescence, apoptosis and the effects of age-
ing show a relationship with OA disease pro-
gression  in  all  joint  compartments.  Here,
ROS/RNS have been proven to be involved in
the regulation of each of these factors.
Preterm  cellular  senescence  has  been
addressed to play an important role in OA. The
phenomenon of cellular senescence has been
described for the first time by Hayflick in the
60’s  of  the  last  century  as  the  inability  of
matured  cells  to  divide  indefinitely.
67 This
Hayflick limit is mainly an effect of telomere
shortening.  Linear  chromosomes  are  capped
by repetitive nucleoprotein structures, called
telomeres. Each cell division results in a pro-
gressive shortening of telomeres that, below a
certain threshold, promotes genome instabili-
ty, senescence, and apoptosis. Telomeres are
highly sensitive against ROS induced instabil-
ity  due  to  their  high  content  of  guanines.
Therefore,  telomere  length  is  reducing  at  a
faster rate during oxidative stress.
68 There is
evidence that senescence can be induced by
extrinsic factors in chondrocytes by so called
free  radical  induced  stress  senescence.
69
Searching a specific marker for chronic expo-
sure to oxidative stress, irreversible telomere
length  shortening  was  discussed.
70,71 These
facts  imply  a  connection  between  oxidative
stress and OA development. Yet, to date the
amount  of  data  on  the  impact  of  telomere
length shortening under in vivo conditions in
tissues other than the hematopoietic system is
limited. 
There are two clinical presentations of OA
that are possibly associated with free radical
Article
Figure 2. Depicts the diagrammed hypothesized interrelationship between the clinical
symptoms of osteoarthritis and oxidative dysbalance, attributed to the relevant compart-
ments of the joint.[page 98] [Orthopedic Reviews 2010; 2:e23]
induced cellular senescence:
First, there is few data on the exact mecha-
nisms that promote joint capsule thickening by
fibrosis and consecutive stiffness. The cellular
mechanism of fibrosis control is regulated by
cellular  senescence  in  at  least  one  tissue.
72
Since  fibrosis  is  a  common  feature  of  OA,
intraarticular paracrine ROS/NOS messaging
might be beneficial for limitation of capsule
fibrosis by promoting senescence of proliferat-
ing fibroid cells.
Second, joint inflammation is another char-
acteristic  finding  in  OA  with  often  acute
insert,  leading  to  pain  and  swelling  of  the
affected  joint.  Beside  immunogenic  cells  a
huge number of other cell types are involved in
inflammation, in the context of OA pathogene-
sis  particularily  fibroblasts.
73 The  first  study
showing  an  inflammatory  response  by  mes-
enchymal cells was performed on skin fibrob-
lasts. The inflammation involved the transcrip-
tional upregulation of cytokines, such as inter-
leukins  (IL-1,  IL-15),  their  receptors  and
chemotactic secreted factors.
74 This coordinat-
ed secretion of proinflammatory molecules is a
result of cellular senescence.
75 It is likely that
ROS induced senescence of synovial and carti-
lage cells can promote the inflammatory tran-
sition of the osteoarthritic joint.
Free radical damage induced cell apoptosis
provides a strategy to ensure the survival of
the organism by scavenge of damaged cells.
The process of apoptosis is initiated by activa-
tion of caspases (cysteine-aspartic-acid-pro-
teases), a process that what was long time
considered to be is irreversible once started.
Free radical species have been shown to pro-
mote apoptosis
76 by activation of c-Jun N-ter-
minal kinases (JNK) and p38 Mitogen-acti-
vated  protein  (MAP)  kinases  via  apoptosis
signal-regulating  kinase  (ASK)  1.
77 Inter -
estingly, within this pathway free radicals are
formed  as  a  second  messenger  amplifying
ASK1  activation  leading  to  cell  death  even
within ROS concentrations that are not suffi-
cient to initiate apoptosis.
78
Today, chondrocytic death in OA has been
examined in various studies, most of which
report an increased amount of apoptotic cell
death.
79 Besides other stimuli, exogenous and
endogenous  NO  has  been  proven  to  induce
chondrocyte apoptosis by intracellular induc-
tion of ROS.
80 The cytotoxic effect is a result of
increased ROS load and formation of cytotoxic
peroxynitrit  by  direct  reaction  of  NO  and
ROS.
81,82 Vice  versa,  chondrocyte  apoptosis
induced by toxins can be suppressed by hypox-
ia  shifting  chondrocytes  to  a  less  oxidative
intracellular state.
83 An accumulation of carti-
lage matrix proteins in the endoplasmic retic-
ulum  and  Golgi  apparatus  of  chondrocytes
modified by oxidant stress during aging has
been discussed as a cause for decreased syn-
thesis of cartilage matrix proteins and eventu-
al chondrocyte apoptosis.
84
Most  studies  on  apoptosis  and  OA  are
focused on cartilage tissue, only few data exist
about the relevance of cell death in the other
joint compartments. Furthermore, most stud-
ies are performed in advanced OA stages on
cartilage explants obtained during total joint
replacement  surgery.  In  contrast,  little  is
known about the function of apoptosis in early
stage OA.
Aging leads to impaired extracellular matrix
composition.  A  dysbalance  of  chondrocyte
function  in  favor  of  catabolic  action  against
extracellular matrix synthesis increases with-
in aging. Studies measuring changes in joint
cartilage using MRI gathered evidence that its
thickness  decreases  with  significant  age
dependency.
85 Also hydration, decline of cellu-
larity and a gradual loss of cartilage matrix are
reported in aged cartilage leading to a weaken-
ing of tissue.
86
Interestingly, the joint is capable of adapting
to oxidative stress induced by extrinsic factors
if  it  is  not  subject  to  pathologic  alterations.
Repetitive and cyclic mechanical stress, e.g. in
long  distance  running  does  not  induce  pro-
gressive knee OA.
87 The crucial biomechanical
cause seems to be excessive load within over-
weight or joint malalignement, or the combi-
nation of such factors.
88,89
As a result of the slow metabolism and low
proliferation rate of cartilage tissue chondro-
cytes and cartilage extracellular matrix colla-
gens lack the turnover most tissues show. A
theory of aging with relevance for cartilage
degeneration  is  the  assumption  that  cells
gather damage by free radicals produced by
the  electron  transport  chain  in  mitochon-
dria.
90 Cartilage  tissue  is  highly  sensitive
against cumulative effects of extrinsic factors
like  oxidative  stress.
91 There  is  evidence  of
the  accumulation  of  nonenzymatic  glycated
and oxidized proteins, so called advanced gly-
cation  endproducts  (AGEs)  in  joint  carti-
lage.
92,93 The production of AGEs is increased
in diabetic individuals.
94 The influence of AGE
accumulation  on  chondrocyte  function  is
mediated by specific receptors for advanced
glycation endproducts (RAGE) located on the
membrane  of  chondrocytes.  They  show  an
increased expression in aging and during OA
development.
95 Stimulation of these receptors
leads  to  an  increased  expression  of  matrix
metalloproteinases  followed  by  increased
catabolic  function  of  chondrocytes.
96 The
intracellular  messaging  of  RAGE  has  early
been proven to be ROS dependent. RAGE acti-
vation  in  turn  induces  oxidative  stress,
97
showing one more involvement of oxidative
stress  in  pathologic  alterations  leading  to
joint degradation.
Resulting  from  the  clearly  demonstrated
age dependency of disease development, bio-
chemical  factors  influencing  chondrocyte
function and survival may play a central role
in the pathophysiological cascade leading to
OA
98  and  provide  therefore  therapeutic
options on long-term.
Discussion
The progression of OA from silent cartilage
destruction to painful clinical presentation is
an important subject to further investigation.
The novel approach to OA considers the joint
as a dynamic system of three different tissues
interacting  by  fluid  diffusion  and  paracrine
factors. Because of their chemical properties,
free radicals meet the requirements to medi-
ate and amplify the characteristic sequence of
joint degeneration in all tissues affected, mak-
ing  them  as  well  a  crucial  factor  for  the
involvement of all three joint compartments in
disease development as for the sudden break-
down of compensation leading to inflammato-
ry  transformation  of  osteoarthritic  joints.
Therapeutic  modifications  of  these  mecha-
nisms  may  be  promising  area  of  further
research to achieve comprehension and there-
fore approach to modification of disease pro-
gression.
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